Delap Wealth Advisory, LLC Atri Cure, Inc. Transaction History
Delap Wealth Advisory, LLC
- $247 Billion
- Q1 2024
A detailed history of Delap Wealth Advisory, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Delap Wealth Advisory, LLC holds 8,708 shares of ATRC stock, worth $195,494. This represents 0.11% of its overall portfolio holdings.
Number of Shares
8,708
Previous 9,000
3.24%
Holding current value
$195,494
Previous $321 Million
17.53%
% of portfolio
0.11%
Previous 0.15%
Shares
5 transactions
Others Institutions Holding ATRC
# of Institutions
239Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA4.75MShares$107 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.23MShares$95 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$82 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$60.2 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$36.8 Million0.01% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.04B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...